KellBenx Obtains $2,500,000 New Funding Round

  • Feed Type
  • Date
    4/21/2011
  • Company Name
    KellBenx
  • Mailing Address
    61 Alhambra Road Massapequa, NY 11758
  • Company Description
    KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood. Our focus is to improve women’s healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders.
  • Website
    http://www.kellbenx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.